TCR-mimic bispecific nanobody-based T cell engager targeting intracellular tumor antigens for cancer immunotherapy
Ziqiang Ding(Guangxi Medical University), Xiaoling Lü(Guangxi Medical University), Shuyang Sun(Guangxi Medical University), Xiaomei Yang(University of Maryland, Baltimore), Xianing Huang, Xiaoqiong Hou(Stomatology Hospital), Aiqun Liu(Guangxi Medical University), Shenxia Xie(Guangxi Medical University)
Cited by 0
Related Papers
High salt primes a specific activation state of macrophages, M(Na)
|Cell Research|2015|243
Nanomaterials for Cancer Precision Medicine
|Advanced Materials|2018|212
T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
|The Journal of Immunology|2013|142
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
|International Journal of Nanomedicine|2021|141